Free Trial

Strategic Financial Concepts LLC Has $905,000 Position in The Allstate Corporation (NYSE:ALL)

Allstate logo with Finance background

Strategic Financial Concepts LLC decreased its position in shares of The Allstate Corporation (NYSE:ALL - Free Report) by 35.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,369 shares of the insurance provider's stock after selling 2,378 shares during the quarter. Strategic Financial Concepts LLC's holdings in Allstate were worth $905,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of ALL. Vantage Point Financial LLC grew its position in Allstate by 3.6% during the 1st quarter. Vantage Point Financial LLC now owns 1,495 shares of the insurance provider's stock worth $310,000 after purchasing an additional 52 shares in the last quarter. Confluence Wealth Services Inc. boosted its position in shares of Allstate by 0.7% in the first quarter. Confluence Wealth Services Inc. now owns 8,000 shares of the insurance provider's stock worth $1,558,000 after buying an additional 54 shares during the period. Achmea Investment Management B.V. grew its holdings in shares of Allstate by 0.3% during the first quarter. Achmea Investment Management B.V. now owns 20,586 shares of the insurance provider's stock valued at $4,262,000 after buying an additional 57 shares in the last quarter. Avidian Wealth Enterprises LLC raised its position in Allstate by 1.7% during the first quarter. Avidian Wealth Enterprises LLC now owns 3,552 shares of the insurance provider's stock valued at $735,000 after buying an additional 59 shares during the period. Finally, Private Trust Co. NA lifted its stake in Allstate by 1.0% in the 1st quarter. Private Trust Co. NA now owns 5,995 shares of the insurance provider's stock worth $1,241,000 after acquiring an additional 60 shares in the last quarter. Institutional investors and hedge funds own 76.47% of the company's stock.

Analyst Upgrades and Downgrades

ALL has been the topic of a number of research reports. Barclays dropped their target price on Allstate from $183.00 to $172.00 and set an "underweight" rating on the stock in a report on Friday, April 11th. BMO Capital Markets reiterated an "outperform" rating on shares of Allstate in a research report on Friday, May 16th. JPMorgan Chase & Co. lifted their target price on shares of Allstate from $217.00 to $222.00 and gave the company an "overweight" rating in a research note on Tuesday, April 8th. Wall Street Zen raised shares of Allstate from a "hold" rating to a "buy" rating in a research note on Thursday, May 1st. Finally, Raymond James Financial reissued a "strong-buy" rating and set a $250.00 price objective (up previously from $240.00) on shares of Allstate in a research report on Monday, May 5th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $225.20.

Read Our Latest Report on ALL

Allstate Stock Performance

Shares of Allstate stock traded up $2.03 on Friday, reaching $196.72. The stock had a trading volume of 963,005 shares, compared to its average volume of 1,633,683. The Allstate Corporation has a fifty-two week low of $157.50 and a fifty-two week high of $213.18. The business's 50-day moving average price is $201.30 and its two-hundred day moving average price is $196.58. The company has a debt-to-equity ratio of 0.40, a quick ratio of 0.40 and a current ratio of 0.40. The stock has a market cap of $52.09 billion, a P/E ratio of 13.44, a price-to-earnings-growth ratio of 1.01 and a beta of 0.33.

Allstate (NYSE:ALL - Get Free Report) last released its earnings results on Wednesday, April 30th. The insurance provider reported $3.53 earnings per share for the quarter, missing analysts' consensus estimates of $3.98 by ($0.45). The firm had revenue of $14.30 billion for the quarter, compared to analyst estimates of $16.41 billion. Allstate had a return on equity of 24.62% and a net margin of 6.19%. The firm's revenue was up 7.8% on a year-over-year basis. During the same period in the prior year, the firm earned $5.13 EPS. On average, sell-side analysts forecast that The Allstate Corporation will post 18.74 EPS for the current year.

Allstate Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, July 1st. Shareholders of record on Monday, June 9th were issued a $1.00 dividend. This represents a $4.00 dividend on an annualized basis and a yield of 2.03%. The ex-dividend date was Monday, June 9th. Allstate's dividend payout ratio (DPR) is currently 27.32%.

Allstate Company Profile

(Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

See Also

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

Should You Invest $1,000 in Allstate Right Now?

Before you consider Allstate, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.

While Allstate currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines